Market Access
Market access for medical devices in Europe: England, France, Germany, Italy and Spain
Market access for in-vitro diagnostic tests in Europe: England, France, Germany, Italy and Spain
Market Access Landscape for Health Apps in Europe
Reimbursement Pathways for Companion Diagnostic (CDx) Tests in Europe
Case Study: Market Access for Mechanical Thrombectomy in England
Case study: Market Access Pathway for TAVI in France
Case study: Market Access for Preeclampsia Predictive Tests in Germany and Norway
Challenges of HTA and Reimbursement Submissions for Medical Devices
Evidence Requirements
Evidence Gap Analysis for Medical Technologies in Europe – a Practical Example
Evidence requirements for LPPR List process in France, part 1
Evidence requirements for LPPR List process in France, part 2
Evidence requirements for reimbursement of diagnostic (non-IVD) methods in France
Evidence Requirements for Interventional Procedures Program at NICE in the United Kingdom
Evidence requirements for coverage of medical technologies in the Netherlands
Evidence requirements for medical devices in the regional HTA program in Italy
Evidence requirements for Med Tech Early Value Assessment at NICE in the United Kingdom
Value Dossiers for Medical Technologies: What, When and How?
Challenges and Proposed Solutions in SLR for Medical Devices